Você procurou por: eritropoezo (Esloveno - Inglês)

Če se trenutno ne zdravite z zdravili, ki spodbujajo eritropoezo
if you are not currently treated with an esa

Če se trenutno zdravite z drugim zdravilom, ki spodbuja eritropoezo
if you are currently being treated with another esa

darbepoetin alfa spodbuja eritropoezo prek istih mehanizmov kot endogeni hormon.
darbepoetin alfa stimulates erythropoiesis by the same mechanism as the endogenous hormone.

zdravila, ki zmanjšujejo eritropoezo, lahko zmanjšajo odziv na epoetin alfa.
medicinal products that decrease erythropoiesis may decrease the response to epoetin alfa.

et v kontroliranih kliničnih študijah je uporaba nespa in drugih eritropoezo stimulirajočih agensov
th in patients with anaemia associated with cancer.

humani eritropoetin je endogen glikoproteinski hormon, ki primarno uravnava eritropoezo, in sicer
human erythropoietin is an endogenous glycoprotein hormone that is the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cells in the bone marrow.

ugotovljeno je, da ta protitelesa navzkrižno reagirajo z vsemi zdravili, ki spodbujajo eritropoezo.
pure red cell aplasia caused by anti-erythropoietin antibodies has been reported in association with esas.

preveliko odmerjanje se lahko izrazi s pretiranim farmakodinamičnim učinkom, na primer s čezmerno eritropoezo.
overdose can result in manifestations of an exaggerated pharmacodynamic effect, e.g. excessive erythropoiesis.

et v kontroliranih kliničnih študijah je uporaba nespa in drugih eritropoezo stimulirajočih agensov (esa):
th in patients with anaemia associated with cancer.

zdravilo mircera spodbuja eritropoezo prek interakcije z eritropoetinskim receptorjem, ki se nahaja na progenitornih matičnih celicah v kostnem mozgu.
mircera stimulates erythropoiesis by interaction with the erythropoietin receptor on progenitor cells in the bone marrow.

v kliničnih študijah so ugotovili večje tveganje smrti, resnih srčnožilnih dogodkov, in tromboze na žilnem dostopu kadar so eritropoezo do
increased risk of death, serious cardiovascular events, and vascular access thrombosis was observed when erythropoiesis-stimulating agents (esas) were administered to target a haemoglobin of greater a

tudi mircera je kot druga zdravila, ki spodbujajo eritropoezo, rastni dejavnik, ki primarno spodbuja nastajanje rdečih krvnih celic.
mircera, like other esas, is a growth factor that primarily stimulates red blood cell production.

potrebovali dodatno železo za zvečanje ali ohranitev nasičenosti transferina in koncentracije feritina na ravni, potrebni za ustrezno eritropoezo, ki jo spodbudi dynepo.
virtually all patients will eventually require supplemental iron to increase or maintain transferrin saturation and ferritin to levels that will adequately support erythropoiesis stimulated by dynepo. ro

humani eritropoetin je endogen glikoproteinski hormon, ki primarno uravnava eritropoezo, in sicer preko specifične interakcije z eritropoetinskim receptorjem na eritroidnih matičnih celicah v kostnem mozgu.
human erythropoietin is an endogenous glycoprotein hormone that is the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cells in the bone marrow.

najmanjše stimulacijske koncentracije za eritropoezo dalj časa kot po enakovrednem molarnem odmerku r- huepo; tako je mogoče z manj pogosto uporabo darbepoetina alfa doseči enak biološki ilo
due to its increased carbohydrate content the level of darbepoetin alfa in the circulation remains above the minimum stimulatory concentration for erythropoiesis for longer than the equivalent molar dose of r-huepo, allowing darbepoetin alfa to be administered less frequently to achieve the same biological response.

b03xa02. lje humani eritropoetin je endogen glikoproteinski hormon, ki primarno uravnava eritropoezo, in sicer preko specifične interakcije z eritropoetinskim receptorjem na eritroidnih matičnih celicah v kostnem vo mozgu.
human erythropoietin is an endogenous glycoprotein hormone that is the primary regulator of erythropoiesis through specific interaction with the erythropoietin receptor on the erythroid progenitor cells in the bone marrow.

pri uporabi tega zdravila so opazili zmanjšano uporabo intravenskega železa in eritropoezo stimulirajočih snovi (esa- erythropoiesis-stimulating agent).
reductions in intravenous iron and erythropoiesis-stimulating agent (esa) use with this medicine have been observed.

pokazalo se je, da epoetin alfa spodbuja eritropoezo pri anemičnih bolnikih s kronično ledvično odpovedjo, vključno z bolniki, ki se zdravijo z dializo, in s tistimi, ki se z dializo še ne zdravijo.
epoetin alfa has been shown to stimulate erythropoiesis in anaemic patients with crf, including dialysis and pre-dialysis patients.

okužba s parvovirusom b19 lahko resno ogroža nosečnice (okužba ploda) in posameznike z imunsko pomanjkljivostjo ali povečano eritropoezo (npr. hemolitična anemija).
parvovirus b19 infection may be serious for pregnant women (foetal infection) and for individuals with immunodeficiency or increased erythropoiesis (e.g. haemolytic anaemia).

in vitro (celična kultura mišje vranice) so ugotovili povečan obseg vgrajevanja 3h- timidina v eritroidne vranične celice z jedrom po inkubaciji z eritropoetinom. v raziskavah na celičnih kulturah človeškega kostnega mozga so ugotovili, da eritropoetin specifično stimulira eritropoezo in da na levkopoezo ne vpliva.
it could be shown with the aid of cell cultures of human bone marrow cells that erythropoietin stimulates erythropoiesis specifically and does not affect leucopoiesis.